Brain Injury Diagnostics Workshop Planned By FDA
This article was originally published in The Gray Sheet
Executive Summary
The workshop will evaluate potential diagnostics, development strategies and datasets for traumatic brain injury. Multiple firms are working to bring different technologies for concussion detection to market.
You may also be interested in...
Heightened Concussion Awareness Calls For New Detection Tools
Medical device start-ups are surging into new territory in mild traumatic brain injury or concussion detection, which has heretofore lacked objective diagnostics and monitoring tools. Profiles of Cerora, MC10, Oculogica, and Sway Medical.
Banyan Readies For Pivotal Study Of Molecular Dx For Traumatic Brain Injury
Banyan Biomarkers blood-based assay works by detecting the presence of two proteins that only cross the blood-brain barrier if there’s been a brain injury. An IDE was filed July 2 and the firm hopes for PMA approval in 2014.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.